Translocation Renal Cell Carcinoma t(6;11)(p21;q12) and Sickle Cell Anemia: First Report and Review of the Literature
´ëÇѺñ´¢±â°úÇÐȸÁö 2014³â 55±Ç 2È£ p.145 ~ p.147
(Chaste Damien) - Rennes University Hospital Department of Urology
(Vian Emmanuel) - Pointe a Pitre University Hospital Department of Urology
(Blanchet Pascal) - Pointe a Pitre University Hospital Department of Urology
(Verhoest Gregory) - Rennes University Hospital Department of Urology
Abstract
Translocation renal cell carcinoma (RCC) is a family of rare tumors recently identified in the pediatric and young adult population. We report the first case of a young woman from French West Indies with sickle cell anemia who developed a translocation RCC t(6;11)(p21;q12). Usually people with the sickle cell condition are known to develop renal medullary carcinoma (RMC). To our knowledge, this is the first case described in the literature of a translocation RCC associated with sickle cell disease. Here we discuss the relation between translocation RCC, RMC, and sickle cell disease.
Å°¿öµå
Hemoglobin SS, Kidney cancer, Renal cell carcinoma, Sickle cell anemia, Transcription factor EB
KMID :
0358320140550020145
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)